RESUMO
BACKGROUND AND AIMS: Inflammation and proliferation are the cause of benign prostatic hyperplasia (BPH) and are the key components of its mechanism of action. In this study we sought to determine the role of 25-hydroxyvitamin D in BPH, because of its anti-inflammatory activities, and its effect on prostate volume and BPH symptoms. METHODS: This randomized clinical trial (RCT) was conducted on 108 participants >50 years of age who had either asymptomatic or mild BPH symptoms according to the International Prostate Symptom Score (IPSS) questionnaire. Patients were randomly divided into two groups, intervention and control. The intervention group received 50 000 units of vitamin D3 and the control group received a placebo every two weeks for six months. Prostate ultrasound, routine clinical examinations, toucher rectal (TR), and laboratory tests were performed for all patients. After six months, the patients underwent another ultrasound evaluation, measurement of prostate-specific antigen (PSA) levels and completed the IPSS. Results of the evaluations before and after the intervention were compared between the groups using the chi-square, t-test, and logistic regression analysis. Repeated measure analysis was used to evaluate the effect of vitamin D intervention on the changes in the IPSS score. RESULTS: The mean age of the participants was 56 ± 9 years. In the control group, the mean prostate volume was higher compared to the intervention group (p < 0.001). The control group had a higher mean PSA level than the intervention group (p < 0.001). Although the IPSS score decreased over time in both groups, analysis of variance showed that the amount of change or decrease in IPSS score in the intervention group was significantly more than the control group (p < 0.001). CONCLUSIONS: The results of our study support the effect of vitamin D in reducing prostate volume and PSA levels, and in improving BPH symptoms. Further studies are needed to confirm these findings to verify the use of vitamin D as a treatment for BPH.
Assuntos
Anti-Inflamatórios , Hiperplasia Prostática , Vitamina D , Idoso , Anti-Inflamatórios/farmacologia , Anti-Inflamatórios/uso terapêutico , Suplementos Nutricionais , Progressão da Doença , Humanos , Irã (Geográfico) , Masculino , Pessoa de Meia-Idade , Próstata/efeitos dos fármacos , Próstata/patologia , Antígeno Prostático Específico/sangue , Hiperplasia Prostática/tratamento farmacológico , Hiperplasia Prostática/epidemiologia , Hiperplasia Prostática/patologia , Hiperplasia Prostática/fisiopatologia , Inquéritos e Questionários , Vitamina D/farmacologia , Vitamina D/uso terapêuticoRESUMO
Dielectric barrier discharge (DBD) plasma has been recently used for removal of synthetic organic compounds (SOCs) from aqueous environments. The removal of SOCs by alone DBD is significantly limited by its high electricity needs and inefficient mineralization, which affects the further application of DBD for SOCs. The combined application of DBD with other technologies and the addition of a supplementary substance for energy-saving were proposed to resolve these problems. The addition of catalysts is considered to be a promising and innovative approach to increase the energy yield of DBD, improve the environment friendly of DBD, develop the variety of goal SOCs, and improve the removal efficiency of DBD system. Despite the increasing use of the coupling form of DBD and catalysts, as catalytic dielectric barrier discharge (CDBD), but it still requires a comprehensive review to summarize the last studies and highlight the future perspectives in this area. Therefore, this work is the first literature review aimed to critically assess the latest developments of catalysts coupling with DBD employed in aqueous environments. Moreover, performance evaluation, energy yield, toxicity, eco-friendly, and future perspectives of the CDBD systems for SOCs removal were discussed and overviewed. The results showed that the coupling of catalysts with DBD presents synergistic effects and had excellent removal performance for aqueous SOCs. Overall, it can be concluded that the essential principles of environmental and economic sustainability have been addressed for the removal of persistent pollutants from aqueous environments in the CDBD systems.